A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Vivani Medical is working on an implant form of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes medication Ozempic. According to CNBC, the implant aims to help patients maintain their weight loss.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton